Showing 1 - 5 results of 5 for search 'Sulav Duwal' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Sulav Duwal
Showing 1 - 5 results of 5 for search 'Sulav Duwal', query time: 0.05s Refine Results
  1. 1
    Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection.

    Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection. by Sulav Duwal, Christof Schütte, Max von Kleist

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

    Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection. by Sulav Duwal, Christof Schütte, Max von Kleist

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.

    Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis. by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.

    Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes. by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2018-06-01
    Get full text
    Article
  5. 5
    The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis

    The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis by Sulav Duwal, Daniel Seeler, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2019-03-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs